Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-25-000143

Co-Chief Executive Officer bought 338,394 shares at an average $17.69 ($5,984,756)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-10 Purchase : show line 1 in the form +333,394 $17.68 $5,894,406 556,088,090 I
2025-09-11 Purchase : show line 2 in the form +5,000 $18.07 $90,350 556,093,090 I
Open-market purchases · 338,394 sh · avg $17.69 · $5,984,756
Loading xslF345X05/wk-form4_1757633787.xml…